These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36863030)

  • 1. Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia.
    Yang S; Wang H; Zheng GF; Wang Y
    Ther Drug Monit; 2023 Oct; 45(5):676-682. PubMed ID: 36863030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.
    Ding J; Zhang Y; Zhang Y; Yang L; Zhang S; Cui X; Meng Z; Li Y; Xing H
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):552-559. PubMed ID: 36286707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and combined meta-analysis of concentration of oral amisulpride.
    Li L; Li L; Shang DW; Wen YG; Ning YP
    Br J Clin Pharmacol; 2020 Apr; 86(4):668-678. PubMed ID: 32090363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride.
    Sun F; Yu F; Gao Z; Ren Z; Jin W
    Asian J Psychiatr; 2021 Aug; 62():102694. PubMed ID: 34052710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level.
    Huang S; Li L; Wang Z; Xiao T; Li X; Liu S; Zhang M; Lu H; Wen Y; Shang D
    Drug Des Devel Ther; 2021; 15():3903-3913. PubMed ID: 34548782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data.
    Qu K; Zhou Q; Tian L; Shen Y; Zhou Z
    Int Clin Psychopharmacol; 2022 Nov; 37(6):255-262. PubMed ID: 35779068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
    Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).
    Reeves S; Eggleston K; Cort E; McLachlan E; Brownings S; Nair A; Greaves S; Smith A; Dunn J; Marsden P; Kessler R; Taylor D; Bertrand J; Howard R
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):396-404. PubMed ID: 28643852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Reeves S; McLachlan E; Bertrand J; D'Antonio F; Brownings S; Nair A; Greaves S; Smith A; Taylor D; Dunn J; Marsden P; Kessler R; Howard R
    Brain; 2017 Apr; 140(4):1117-1127. PubMed ID: 28334978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Canal M; Loc'h C; Mazière B; Paillère-Martinot ML
    J Clin Psychopharmacol; 2001 Apr; 21(2):207-14. PubMed ID: 11270918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.
    Liang Y; Cao C; Zhu C; Wang C; Zhang C; Dong F; Yang F; Deng H; Yu J; Tang J; Su L; Xin L; Hong L; Gao M; Tang M; Xie S; Lu S; Liu T; Xu X; Wang X; Li X; Wang X; Li Y; Zhang Y; Chen Z; Yu X
    Asia Pac Psychiatry; 2016 Sep; 8(3):241-4. PubMed ID: 27020720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy.
    Lerner V; Bergman J; Borokhov A; Loewenthal U; Miodownik C
    Clin Neuropharmacol; 2005; 28(2):66-71. PubMed ID: 15795548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of Steady-State Olanzapine Concentrations in Chinese Patients Using Therapeutic Drug Monitoring: Effects of Valproate and Other Factors.
    Deng SH; Wang ZZ; Lu HY; Li L; Hu JQ; Zhu XQ; Xie HS; Chen HZ; Zhang M; Ni XJ; Qiu C; Shang DW; Wen YG
    Ther Drug Monit; 2020 Aug; 42(4):636-642. PubMed ID: 32039940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
    Riedel M; Eich FX; Möller HJ
    Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.